Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Vilex LLC is managing 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are split between 2 distinct examiners and 2 distinct art units. This distribution indicates that each of the pending office actions is being reviewed by a different examiner in a different specialized unit. Such a spread suggests that the company's current medical device filings are diverse enough to fall under the jurisdiction of two separate examination groups, rather than being concentrated in one.
PELLEGRINO, BRIAN E is identified as the busiest examiner for the portfolio, currently handling 1 pending office action. This represents a portion of the 2 pending office actions active for the company. With multiple distinct examiners and art units involved, the company's prosecution is currently diversified across different examination environments. This lack of concentration means that the company must address the specific requirements of each examiner, each managing 1 pending office action, which may lead to different timelines and outcomes for the two pending matters.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PELLEGRINO, BRIAN E | 1 | 55.4% | +35.9% |
| SIPP, AMY R. | 1 | 71.1% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18372410 | ANKLE ARTHROPLASTY DEVICES, SYSTEMS, AND METHODS | PELLEGRINO, BRIAN E | 15d |
| 18125626 | SYNDESMOSIS TENSIONING INSTRUMENTS, IMPLANTS, SYSTEMS, AND METHODS | SIPP, AMY R. | 57d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18372410 | ANKLE ARTHROPLASTY DEVICES, SYSTEMS, AND METHODS | PELLEGRINO, BRIAN E | 15d |
| 18125626 | SYNDESMOSIS TENSIONING INSTRUMENTS, IMPLANTS, SYSTEMS, AND METHODS | SIPP, AMY R. | 57d |
| Art Unit | Apps |
|---|---|
| 3799 | 1 |
| 3775 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18372410 | ANKLE ARTHROPLASTY DEVICES, SYSTEMS, AND METHODS | PELLEGRINO, BRIAN E | 3799 | §103§112 | Final Rejection | 15d | Pending | Sep 25, 2023 |
| 18125626 | SYNDESMOSIS TENSIONING INSTRUMENTS, IMPLANTS, SYSTEMS, AND METHODS | SIPP, AMY R. | 3775 | §102§103§112 | Non-Final OA | 57d | Pending | Mar 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVilex LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Brian E Pellegrino has the most, with 1 of Vilex LLC's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
